Health Condition 1: B108- Other human herpesvirus infection
Conditions
Interventions
None listed
Sponsors
Sanjay Gandhi Post Graduate Institute of Medical Sciences
Eligibility
Inclusion criteria
Inclusion criteria: All adult ICU patients (age >= 18 years) who had septic shock will be considering for inclusion in this study.
Exclusion criteria
Exclusion criteria: 1.Consent not given. 2.Expected survival 3.Use of antiviral agent cidofovir, foscarnet, ganciclovir, valgancyclovir [HSV treatment doses of acyclovir, valacyclovir, or famciclovir permitted]) within the last 7 days. 4.Known or suspected underlying immune deficiency [history of solid organ or stem cell transplantation, infection with the human immunodeficiency virus, hematological malignancy, use of immunosuppressive medication (more than 0.1 mg prednisone per kilo for more than 3 months, more than 75 mg prednisone per day for more than 1 week, or equivalent), chemotherapy/radiotherapy in the year before ICU admission, and any known humoral or cellular immune deficiency]. 5.Pregnancy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. To study the prevalence of CMV reactivation in critically ill septic shock patient.Timepoint: 2 years | — |
Secondary
| Measure | Time frame |
|---|---|
| Determine the association of CMV reactivation on patient outcomes, length of ICU stay as well as on duration of mechanical ventilation on non-immunosuppressed patients with septic shock.Timepoint: 2 years | — |
Countries
India
Contacts
Public ContactAtul Garg
Sanjay Gandhi Post Graduate Institute of Medical Sciences
Outcome results
None listed